Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention

QR Code

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention

Alaa Badawi1, Amira Klip2, Pierre Haddad3, David EC Cole4, Bibiana Garcia Bailo1,5, Ahmed El-Sohemy5, Mohamed Karmali11Office for Biotechnology, Genomics and Population Health, Public Health Agency of Canada, Toronto, ON, Canada; 2Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Ca...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Alaa Badawi, Amira Klip, Pierre Haddad, et al
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/88cbf4885f79403282a0b01e525c965a
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
par: Badawi A
Publié: (2010)

The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
par: Da Costa LA, et autres
Publié: (2012)

Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials
par: J&oslash;rn Ditzel, et autres
Publié: (2009)

Mechanism linking diabetes mellitus and obesity
par: Al-Goblan AS, et autres
Publié: (2014)

Metabolic syndrome in hemodialysis patients as a risk factor for new-onset diabetes mellitus after renal transplant: a prospective observational study
par: Bonet J, et autres
Publié: (2013)

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
par: Angel Rodr&iacute;guez, et autres
Publié: (2010)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
par: Pamela Kushner
Publié: (2010)

Management of gestational diabetes mellitus
par: Annunziata Lapolla, et autres
Publié: (2009)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
par: Peter J Donovan, et autres
Publié: (2010)

Psychosocial interventions for the diabetic patient
par: Harvey JN
Publié: (2015)

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
par: Lorber D
Publié: (2014)

Nutritional therapy for the management of diabetic gastroparesis: clinical review
par: Sadiya A
Publié: (2012)

Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study
par: Usharani P, et autres
Publié: (2013)

Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
par: Tafere GG, et autres
Publié: (2020)

Glucose estimation in the salivary secretion of diabetes mellitus patients
par: Abikshyeet P, et autres
Publié: (2012)

Evidence-based diabetes nutrition therapy recommendations are effective: the key is individualization
par: Franz MJ, et autres
Publié: (2014)

Relationship between insulin resistance and plasma vitamin D in adults
par: Badawi A, et autres
Publié: (2014)

Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan
par: Bakkar MM, et autres
Publié: (2017)

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
par: Ogedengbe OS, et autres
Publié: (2015)

Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq
par: Mansour AA, et autres
Publié: (2014)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
par: Shannon A Miller, et autres
Publié: (2009)

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
par: Mazzilli R, et autres
Publié: (2015)

Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
par: Dara P Schuster
Publié: (2010)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
par: Holl, et autres
Publié: (2014)

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus
par: Feher M, et autres
Publié: (2013)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
par: Omoto S, et autres
Publié: (2015)

Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
par: Mohammed AE, et autres
Publié: (2015)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
par: Petersen AB, et autres
Publié: (2013)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
par: Irons BK, et autres
Publié: (2014)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
par: Stanley Schwartz, et autres
Publié: (2010)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
par: Irons BK, et autres
Publié: (2017)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
par: Jason Seewoodhary, et autres
Publié: (2010)

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
par: Ofori SN, et autres
Publié: (2014)

Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus
par: Liang ZH, et autres
Publié: (2019)

Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis
par: J&oslash;rn Ditzel, et autres
Publié: (2010)

Optimizing weight control in diabetes: antidiabetic drug selection
par: S Kalra, et autres
Publié: (2010)

TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
par: Shitalkumar P Zambad, et autres
Publié: (2011)

Nutrition therapy for type 2 diabetes: confirmed efficacy on individualized management
par: Wei FX, et autres
Publié: (2018)

Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience
par: Juarez DT, et autres
Publié: (2014)

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
par: Yang F, et autres
Publié: (2015)